Inogen Inc (INGN) - Total Liabilities
Based on the latest financial reports, Inogen Inc (INGN) has total liabilities worth $103.02 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check INGN financial resilience to evaluate the company's liquid asset resilience ratio.
Inogen Inc - Total Liabilities Trend (2011–2025)
This chart illustrates how Inogen Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Inogen Inc balance sheet assets.
Inogen Inc Competitors by Total Liabilities
The table below lists competitors of Inogen Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Austral Resources Australia Ltd
AU:AR1
|
Australia | AU$78.69 Million |
|
Userjoy Technology Co Ltd
TWO:3546
|
Taiwan | NT$885.37 Million |
|
Dynacons Systems & Solutions Limited
NSE:DSSL
|
India | Rs6.98 Billion |
|
DAE HWA Pharmaceutical Co. Ltd
KQ:067080
|
Korea | ₩134.61 Billion |
|
Chunil Express
KO:000650
|
Korea | ₩42.56 Billion |
|
Pantech Group Holdings Bhd
KLSE:5125
|
Malaysia | RM349.18 Million |
|
Genesis Land Development Corp.
TO:GDC
|
Canada | CA$307.31 Million |
|
Friedman Industries Inc. Common Stock
NYSE MKT:FRD
|
USA | $172.02 Million |
Liability Composition Analysis (2011–2025)
This chart breaks down Inogen Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See INGN equity to assets ratio to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.10 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.56 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.36 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Inogen Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Inogen Inc (2011–2025)
The table below shows the annual total liabilities of Inogen Inc from 2011 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $106.39 Million | -13.02% |
| 2024-12-31 | $122.33 Million | +0.78% |
| 2023-12-31 | $121.38 Million | +12.77% |
| 2022-12-31 | $107.64 Million | -9.77% |
| 2021-12-31 | $119.29 Million | +6.29% |
| 2020-12-31 | $112.23 Million | +9.26% |
| 2019-12-31 | $102.72 Million | +56.88% |
| 2018-12-31 | $65.47 Million | +36.32% |
| 2017-12-31 | $48.03 Million | +50.28% |
| 2016-12-31 | $31.96 Million | +17.09% |
| 2015-12-31 | $27.30 Million | +24.44% |
| 2014-12-31 | $21.93 Million | -15.95% |
| 2013-12-31 | $26.10 Million | +37.28% |
| 2012-12-31 | $19.01 Million | +14.70% |
| 2011-12-31 | $16.57 Million | -- |
About Inogen Inc
Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen the… Read more